Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Cephalon achieves record sales performance in 2010

Cephalon achieves record sales performance in 2010

11th February 2011

Cephalon has posted its best-ever financial results in 2010 as a result of growing product sales.

The pharmaceutical company generated a record net sales total of $2.76 billion (1.73 billion pounds), representing a year-on-year increase of 28 percent.

Around half of this total was accumulated by Cephalon's growing central nervous system franchise, while the addition of a number of new products from the April 2010 acquisition of Mepha also helped to stimulate sales growth.

As a result of this performance, the company has updated its guidance for the coming year and now expects to record sales of between $3.01 billion and $3.10 billion in 2011.

Kevin Buchi, chief executive officer of Cephalon, said: "We now have one of the premier late stage pipelines in the industry and a geographically diversified business."

The strong results came after a year that saw the passing of Cephalon's previous chief executive officer and founder Dr Frank Baldino Jr from complications associated with leukaemia.ADNFCR-8000103-ID-800399514-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.